Neuromuscular Medicine — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, fellowship access, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Fellowship-level data is genuinely sparse, so several figures below lean on the parent Neurology profile and say so. Last reviewed: 2026-07-26.

Also called: Neuromuscular, NM, "the EMG people." Organ system: the nervous system, specifically its lower half of motor neuron, nerve root, peripheral nerve, neuromuscular junction, and muscle.

Subspecialty fellowship of Neurology (also entered from PM&R and Child Neurology).

The 30-second version

Neuromuscular medicine is the part of neurology that lives below the brainstem, the specialty of weakness, numbness, and wasting, where the question is always "is the lesion in the anterior horn cell, the nerve, the junction, or the muscle?" These are the doctors who diagnose ALS, myasthenia gravis, CIDP and other immune neuropathies, and the muscular dystrophies, and who own the field's signature tool, the electrodiagnostic study (EMG and nerve-conduction studies), a hands-on procedural craft they both perform and interpret. It is mostly daytime, clinic-and-lab work: no stroke pager going off at 3 a.m., long-term relationships with patients you follow for years, and a genuine therapeutic renaissance (SMA gene therapy, new myasthenia biologics) arriving on top of some of medicine's hardest diagnoses. The trade at its center: one of the calmer schedules in neurology and a real diagnostic-plus-procedural identity, set against a heavy emotional load (ALS is terminal) and pay that mostly matches general neurology rather than beating it. Online, the near-consensus is blunt: you do this fellowship for fit and longevity rather than for a raise.

Quick dashboard (details and sources below)
Training after med school 5 years via neurology (PGY-1 + 3 yr neurology + 1 yr fellowship)
Total from college start ~13 years (4 undergrad + 4 med school + 4 neurology residency + 1 fellowship)
Training chain Med school (4) → PGY-1 intern year → 3 yr Neurology → 1 yr Neuromuscular Medicine fellowship
Competitiveness (as a Neuromuscular Medicine fellowship) Low — positions outnumber applicants; many programs go unfilled each cycle ⟳
Typical full-time pay ~$245,000–$310,000 total comp — squarely in the general-neurology band ⟳
vs. general neurology Roughly at par; no reliable premium — EMG volume is the only real lever up ⟳
Lifestyle Outpatient/lab-dominant, structurally low acute call — a notch calmer than general neurology
Burnout No NM-specific figure; parent neurology ~44% (Medscape 2024), sources conflict up to ~48–55% ⟳
% women 53.5% of NM fellows (ACGME, AY2024-25); parent neurology 33% practicing / 50.2% of residents ⟳
DO / IMG accessibility High — 16.3% of NM fellows are osteopathic graduates and 24.4% trained at international medical schools (ACGME, AY2024-25), and the fellowship is uncompetitive ⟳

What they actually do

Neuromuscular specialists diagnose and manage diseases of the peripheral nervous system and muscle: the motor neurons, nerve roots, peripheral nerves, the neuromuscular junction, and the muscle itself. This is the "lower motor" territory that the classic neurology localization exam points to once you've ruled out the brain and cord. Their bread-and-butter conditions are ALS and other motor-neuron diseases, myasthenia gravis and other neuromuscular-junction disorders, peripheral neuropathies (including CIDP and the immune neuropathies), and the muscular dystrophies and other myopathies.1

The signature skill is the electrodiagnostic study, meaning EMG (needle electromyography) and nerve-conduction studies (NCS), which neuromuscular physicians both perform and interpret. This is the field's core procedural craft and the thing that most distinguishes it from cognitive-only neurology; it also overlaps heavily with Clinical Neurophysiology, to the point that the two fellowships are near-substitutes for community EMG work.12 Beyond the needle, the work includes muscle and nerve biopsy interpretation, skin (punch) biopsy for small-fiber neuropathy, neuromuscular ultrasound, and, increasingly, delivery of the field's new biologics and gene therapies (myasthenia and SMA especially).1

Much of the work is longitudinal and relationship-heavy: you follow the same ALS, myasthenia, CIDP, or dystrophy patient for years, often as the leader of a multidisciplinary team. That's a real source of meaning and a real weight, because several of the flagship diseases, ALS above all, are progressive or terminal.1

Representative procedures: nerve-conduction studies (NCS) · needle EMG · advanced electrodiagnostics (single-fiber EMG for myasthenia, repetitive nerve stimulation, quantitative motor-unit analysis) · neuromuscular ultrasound · skin punch biopsy for small-fiber neuropathy · muscle/nerve biopsy interpretation · chemodenervation/botulinum-toxin injection · IVIG and biologic infusion management.12

A day in the life (a typical clinic-and-lab blend): Fellows and attendings describe a week built around "four to five half-days" split between clinic and the EMG lab.2 A morning might be an ALS/MDA multidisciplinary clinic, where the patient sees neurology, pulmonary, PT/OT, speech, nutrition, and social work in a single visit, or a myasthenia or general neuromuscular clinic working up new weakness, numbness, or an elevated CK. Afternoons are commonly in the electrodiagnostic lab, personally running nerve-conduction studies and needle EMG (plus advanced techniques like single-fiber EMG and repetitive nerve stimulation), then dictating the interpretation. Interspersed: infusions and injections (IVIG, complement/FcRn biologics), review of muscle/nerve biopsy slides with pathology, and inpatient consults for myasthenic crisis, Guillain-Barré, and ICU weakness workups. Compared with stroke neurology, it is largely daytime, scheduled, clinic-and-lab work with light acute call. The emotional load rather than the clock is the hard part.23

The training path & time to completion

Medical school (4 yrs) → PGY-1 intern year → 3 years of adult neurology (PGY-2–PGY-4) → 1 year Neuromuscular Medicine fellowship (PGY-5) → board-eligible for the joint ABPN/ABPMR subspecialty certificate.45

  • Fellowship length: 1 year (12 months), ACGME-accredited. ABPMR specifies that at least 6 of the 12 months must be direct clinical care of neuromuscular patients, with the remaining time flexible (research/related study).45
  • Prerequisite residency (multi-entry, a defining feature): you must first complete an accredited residency and hold board certification in one of three fields:45
  1. Neurology (ABPN), the most common route, which is why we file it under Neurology.
  2. Child Neurology (ABPN), the pediatric-neuromuscular on-ramp (SMA, DMD).
  3. Physical Medicine and Rehabilitation, or physiatry (ABPMR), a natural feeder, since PM&R residents already get substantial EMG training.
  • Board / accreditation: the subspecialty is administered jointly by the American Board of Psychiatry and Neurology (ABPN) and the American Board of Physical Medicine and Rehabilitation (ABPMR), one of the few ABMS subspecialties genuinely co-owned by two boards. The joint Committee on Certification was established December 2, 2005, and the first certifying exam was administered in 2008; certification is time-limited (10-year continuing-certification cycle). Fellowships must be ACGME-accredited; international programs aren't accepted.45
  • Total from the start of college: ~13 years via the neurology route (4 undergrad + 4 med school + 4 neurology residency + 1 fellowship). The PM&R route is also ~13 years; the child-neurology route runs ~14 years (child neurology residency is typically 5 years). Consistent with the parent Neurology profile's ~12 years for a general neurologist, plus one fellowship year.14
  • Related credentials (optional but common): many neuromuscular physicians also sit the electrodiagnostic-medicine board (ABEM, the American Board of Electrodiagnostic Medicine, not the emergency-medicine board of the same initials) and pursue the AANEM Neuromuscular Ultrasound Certificate of Added Qualification (CAQ).26

How competitive is it? (as a fellowship)

The honest read is low competitiveness. This is a high-access fellowship where the limiting factor is interest rather than selectivity.

  • No binding national match. Unlike residency, there's no NRMP/SF-Match process here. Applications run through the AANEM Neuromuscular Medicine Fellowship Portal, a centralized soft-match/listing built deliberately to make a previously opaque, first-come process "more fair, equitable, and transparent."78
  • Programs & positions, from two counts that are not the same count. ACGME accredited 59 neuromuscular medicine programs in AY2024-25, with 86 fellows on duty across them; in a one-year fellowship that is roughly 86 seats a year.9 The AANEM fellowship portal lists ~47 programs for the 2027–28 year (~45 ACGME-accredited, a couple non-accredited), which is the programs that use the portal rather than the programs that exist. Read the ACGME figure as the size of the field and the portal figure as the size of the visible application market. In a recent portal snapshot, more than half of the listed programs still showed unfilled positions (1–4 openings each), and the portal explicitly invites continued applications to unfilled programs through late September.7 ⟳
  • The pattern: positions meaningfully outnumber applicants, and a large share of programs go unfilled every cycle, taking candidates in a rolling window after the soft-match. Neuromuscular is intellectually demanding, EMG-heavy, and emotionally weighty (ALS is terminal), so it draws a smaller, self-selected applicant pool rather than a competitive crush. No published mean-Step score or applicant-per-position ratio exists at the fellowship level; limited data.78 ⟳
  • Who enters it: mostly neurology residents (the largest feeder), plus child-neurology and PM&R residents who want electrodiagnostics and nerve/muscle disease. There's substantial overlap with Clinical Neurophysiology, and many programs offer combined or closely linked training, and candidates often choose between (or stack) the two.27

The takeaway for a planner: if you complete a neurology (or PM&R) residency and want this, you can almost certainly get a spot. That accessibility is real, and it's part of why the field's community is candid that people come for the work rather than the prestige.

Compensation — the robust version

Frame everything here against general neurology, because that's where neuromuscular pay sits. It is not a premium procedural track like interventional or endovascular neurology, and not a discount track like pediatric neurology. It lands in the middle, at roughly the general-neurologist number.101112

National number. The best-supported "typical full-time" figure is ~$245,000–$310,000 total comp, converging near ~$270k–$300k.1012 ⟳

  • AMN Healthcare 2025 doesn't break out neuromuscular separately; its general neurology average is $244,000 (starting ~$200,000), a reasonable floor.10
  • AAN 2025 Neurology Compensation & Productivity report doesn't display neuromuscular in its public summary, but its general-neurology median of $309,882 is the best benchmark for the band NM sits in.12 ⟳

Premium or discount against general neurology: effectively at par. There's no consistent subspecialty premium or discount. The nuance: electrodiagnostic (EMG/NCS) billing gives neuromuscular neurologists a genuine production/RVU line that cognitive-only neurologists (headache, behavioral) don't have, so a high-volume EMG reader can out-earn the general-neuro median even though the subspecialty label pays the same. The one published figure for the premium comes from FastRVU, a compensation aggregator rather than a survey, and it puts a busy EMG lab at ~$100k–$150k over clinic-only practice, so read it as a direction rather than a measurement. The reimbursement caveat below cuts against it.101113 ⟳

By setting, academic pays less, and NM is unusually academic. Neuromuscular follows the parent-neurology setting gap: from AAN 2025 by-setting neurology medians, hospital-based group $362,500 · multispecialty group $350,000 · single-specialty group $315,489 · solo $300,000 · academic medical center $277,288 · government $255,000.12 The wrinkle specific to this field: the interesting neuromuscular infrastructure of MDA/ALS multidisciplinary clinics, muscle and nerve biopsy labs, and clinical-trial programs clusters at academic centers, so a larger share of NM specialists sit at the lower-paying academic end than general neurologists do. Private-practice or hospital-employed EMG-heavy roles pay more.12 ⟳

Geography. No neuromuscular-specific geographic data exists; use the parent-neurology pattern, where the Midwest, South, and non-coastal, lower-cost, underserved markets tend to pay neurologists more (shortage-driven premiums, higher locum rates), while saturated high-cost coastal metros often pay less in nominal terms.12 ⟳

How you're paid. Mostly fixed salary plus wRVU incentive (parent neurology: ~34% have wRVU-set base, 65% are incentive-eligible).12 The NM-specific revenue drivers are: (1) EMG/nerve-conduction studies, billed per study/limb and more lucrative per unit time than office E/M; (2) muscle & nerve biopsy interpretation; and (3) in-office infusion and biologic administration, covering IVIG and SCIg for CIDP and myasthenia, complement and FcRn inhibitors for myasthenia, and the new SMA agents, a growing drug-administration revenue stream that mirrors the broader neurology "infusion boom."1314 Locum EMG coverage pays at or above the general-neuro locum range ($143–$250+/hr FTE), but no NM-specific series is published.10 ⟳

The trend that colors all of it. Comp is buoyed by a persistent neurologist shortage, the gene-therapy/biologic wave in neuromuscular disease pulling infusion and specialty-clinic revenue through NM practices, and steady electrodiagnostic demand. The countervailing force the community talks about constantly: CMS has repeatedly cut EMG/NCS reimbursement over the past decade, compressing the procedural upside that historically distinguished neuromuscular and EMG income.13 The result is the field's defining money narrative: you can still out-earn clinic-only peers with volume, but the fellowship itself doesn't reliably raise your salary. ⟳

Lifestyle

Neuromuscular is one of the more controllable neurology subspecialties, outpatient-and-lab dominant, clinic-based, and structurally low on acute and overnight call. This is the biggest single contrast with the parent field: in general neurology the defining lifestyle variable is acute stroke call, and neuromuscular practice largely sits outside that. NM physicians are consult-and-clinic doctors rather than stroke-alert responders.3

  • Hours: broadly the neurology parent's ~45–55 clinical hours/week, with an outpatient-anchored NM practice landing toward the more predictable end (~45–50) because the week is scheduled clinic and EMG-lab days rather than unscheduled emergencies.31
  • Call is the key variable, honestly: light and largely elective. Neuromuscular disease is chronic and referral-based, so there's no time-critical "brain attack" that must be answered overnight. Two real exceptions: myasthenic crisis and Guillain-Barré are genuine inpatient/ICU emergencies (respiratory failure, plasma-exchange and IVIG decisions) that can prompt an urgent consult, but episodically rather than as a nightly pager. And the honest caveat: many NM neurologists in hospital-employed or academic jobs still take a share of general-neurology or stroke call as part of the department rota, especially early-career. The NM work itself is low-call; the job may still bundle general call.3
  • A quiet procedural bonus: EMG and NCS procedure days, unlike clinic days, tend to close out cleanly, because they don't generate the next-day cascade of patient calls, portal messages, and follow-up labs that drives so much neurology inbox burnout (a point NM physicians make often).3

Lifestyle rating: 4/5. Outpatient-dominant, scheduled, procedure-anchored, and structurally insulated from acute stroke call, a notch more controllable than the neurology parent's 3/5. It doesn't reach a 5/5 because many jobs still bundle general call, myasthenic/GBS crises exist, and the emotional load (below) is a real, if non-schedule, cost. If you build a referral-EMG/outpatient practice and negotiate out of general call, this is one of the calmer schedules in neurology.3

Wellbeing — the part to take seriously

Burnout. No neuromuscular-specific figure exists, so use the parent. per Medscape 2024, neurology sits at ~44% burnout, toward the lower-middle tier of specialties, though field-synthesis reporting places neurology higher (~48–55%) depending on instrument and year; don't quote one number as settled.9 NM likely lands at or slightly below the neurology average on the hours/administrative axis (lower call, procedure-day inbox relief, the documented "subspecialization reduces burnout" effect) but above average on the emotional axis (ALS). The burnout driver here is emotional weight plus the prior-auth and reimbursement grind neurology shares, rather than clock-time or stroke call.39 ⟳

"Subspecializing protects you" is a real theme. The strongest argument the community makes for this fellowship is career satisfaction and longevity: narrowing your panel away from the parts of general neurology many find draining (chronic migraine, functional/non-organic complaints) toward a coherent neuromuscular population you actually chose. Greater engagement, longer career. Online, the fellowship is repeatedly framed as a burnout-prevention move, not an income move.3

Emotional load is the defining wellbeing feature. This is where NM diverges most from a "cushy outpatient subspecialty" read. ALS is terminal, and the neuromuscular neurologist owns that relationship from diagnosis to death, often over 2–5 years, in multidisciplinary MDA/ALS clinics, delivering one of medicine's hardest diagnoses repeatedly, then walking the decline with families through feeding tubes, non-invasive ventilation, goals-of-care, and hospice. Muscular dystrophies and many myopathies are also progressive. The counterweight is genuinely growing: SMA gene therapy and the new myasthenia/CIDP biologics mean NM now has dramatic wins alongside the losses (a child with SMA who walks; a myasthenic stabilized). The honest read: high emotional weight, partially offset by a real therapeutic renaissance, and the burden is emotional rather than physical or schedule-driven.315

Career longevity is a relative strength. Like the parent field, NM is largely non-surgical and low in physical demand (EMG is technical but not punishing), so it's practicable well into a later career and adapts to reduced or part-time schedules. The limiter on longevity here is emotional burnout rather than the body, and subspecialty engagement is protective. This is a field people commonly do for a full career.3

Satisfaction / would-choose-again: nobody publishes this, for neuromuscular medicine or for neurology or for any other field. The last would-choose-again table by specialty is roughly 2019, and there is no current overall anchor either, so a percentage you find quoted on an aggregator site has been revived from a retired survey.16 What practitioners themselves describe is meaning, a deep professional identity in the EMG craft and in the long neuromuscular relationships.3

Who's in the field (demographics)

ACGME counts the neuromuscular fellowship separately, and the cohort is small: 86 active fellows in 59 programs in academic year 2024-25. The fellowship figures below are its own; the parent-neurology numbers beside them are context, and a single fellow moves any NM percentage by more than a point.

  • Women: 53.5% of NM fellows, 46 of 86 (ACGME, Table C.21), slightly above the parent field's 50.2% of neurology residents and well above the 33% of practicing neurologists AAMC counts (2022 data), which is a workforce a generation older.17 ⟳
  • DO: 16.3% of NM fellows are osteopathic graduates, 14 of 86 (ACGME, Table C.15), close to parent neurology's 18.8% of the PGY-1 positions that filled in 2026. Low fellowship competitiveness means access for DO neurology and PM&R graduates is genuinely open.18 ⟳
  • IMG: 24.4% of NM fellows trained at international medical schools, 21 of 86 (ACGME, Table C.15), a little above the parent field's 22.4% of filled PGY-1 neurology positions in 2026. ACGME's category counts where a person went to medical school rather than citizenship. Another 5.8% trained in Canada.18
  • URiM: neurology is repeatedly cited as below-average for URiM representation (Black and Hispanic/Latino physicians underrepresented relative to the US population); AAN runs active diversity initiatives. No neuromuscular-specific URiM figure exists; limited data.19 ⟳

Culture, personality & the online stereotypes

Who gravitates here: the "hands-and-brain" neurologist, someone who loves both the localization puzzle (anterior horn? nerve? junction? muscle?) and a procedural, technical craft (EMG/NCS is a real skill you own and keep getting better at for years). NM draws people who want the intellectual richness of neurology but also want to do something with their hands, plus those who value deep longitudinal relationships and are willing to shoulder terminal disease. Detail-oriented pattern-recognizers, comfortable with rare disease and diagnostic ambiguity, often described as the neurologists who like being the "doctor's doctor," the referral endpoint other neurologists send their hardest weakness and neuropathy cases to.3

The stereotypes. Community caricatures rather than facts, each with a kernel of truth and an unfair edge:

  • "The EMG jockey." The online read is that NM people are electrodiagnostics nerds in love with the needle and the trace. The kernel: EMG genuinely is the field's signature, and a big part of both the draw and the income. The unfair edge: it flattens NM to a procedure, when the diagnostic reasoning, biopsy interpretation, and immunotherapy management are just as central, and plenty of NM docs are as cerebral as any neurologist.
  • "The calm, cerebral, low-drama subspecialty." Largely true on schedule, being outpatient with no stroke pager, but it quietly understates the ALS emotional load. "Calm lifestyle" is not the same as "emotionally easy."
  • "The saddest clinic in neurology." The kernel is real (ALS is terminal), but practitioners push back hard: the longitudinal relationships are described as among the most meaningful in medicine, and the therapy pipeline (SMA, myasthenia, CIDP) has shifted the emotional tenor from "diagnose and manage decline" toward real intervention.
  • "A fellowship you do for love, not money." Stated online almost as fact: NM doesn't reliably raise your salary above general neurology, and EMG reimbursement got cut, so people choose it for fit and longevity. Plenty of NM docs do out-earn general peers via high-volume EMG labs, so it isn't a vow of poverty, but "passion, not paycheck" is the dominant community framing.

And plenty don't fit the mold: there are procedure-averse NM docs who work as pure clinical diagnosticians, and frankly business-minded ones who build lucrative EMG practices. The caricatures are directional, not deterministic.

What people say online (synthesized and paraphrased, not quotes): across trainee and physician forums the tone is content and quietly confident. Recurring themes: (1) NM is one of the best lifestyle bets in neurology because it dodges stroke call, a point repeated often; (2) the fellowship is worth it for career satisfaction and burnout prevention rather than a salary bump, and people are explicit that income shouldn't be the reason; (3) EMG reimbursement cuts are a common gripe, though EMG labs still out-earn clinic-only work; (4) NM-trained against Clinical-Neurophysiology-trained is a live debate, where NM certification is preferred for academic and board purposes, but community EMG practice barely distinguishes the two; (5) the job market is strong, being uncompetitive to enter with high demand for NM and EMG skills and good negotiating power; (6) the emotional weight of ALS is acknowledged as real but framed as meaningful rather than merely grim, especially with new therapies.3

Voices from the field. Paraphrased from public writing, with links to the originals:

  • An experienced practitioner in public discussion argues the neuromuscular fellowship should be pursued for fit and longevity rather than salary, since reimbursement shifts unpredictably but subspecializing away from the conditions you find draining is what keeps you in the game for a full career.20
  • Other SDN discussion frames NM as a genuinely good-lifestyle field with minimal emergency responsibility, and stresses that the training gives real depth beyond residency in nerve and muscle biopsy interpretation and comfort with immunotherapy, not just electrodiagnostics.21
  • Comparing subspecialties, practitioners note NM appeals to those who value comprehensive, longitudinal relationships and procedural ownership, and who can shoulder the emotional investment of progressive disease, a different temperament than the efficiency-driven movement-disorders clinic.22
  • The ALS-care literature repeatedly frames the neuromuscular physician's role in the multidisciplinary clinic as one of the most demanding and most rewarding relationships in neurology, walking patients and families through a terminal course while coordinating a whole team.15

Why people choose it / why people leave

Why choose it: best-in-neurology lifestyle for the intellectually serious, being outpatient-dominant, scheduled, and structurally low on acute and overnight call · a real procedural craft (EMG/NCS) you own and refine for a career, hands and brain, plus biopsy interpretation and immunotherapy · a genuine therapeutic golden age (SMA gene therapy, new myasthenia biologics, CIDP therapies) · deep longitudinal relationships and a coherent, chosen patient population · strong demand and an easy job market · burnout-protective subspecialization · a procedural income lever (a high-volume EMG lab) if you want it.

Why leave or avoid it: the ALS emotional load, with repeated terminal diagnoses and years-long decline, the single heaviest cost · pay that doesn't reliably beat general neurology, with EMG reimbursement cut · many jobs still bundle general-neuro/stroke call · neurology's prior-auth and reimbursement grind for expensive biologics · rare, complex disease and diagnostic ambiguity aren't for everyone · less tele-flexible than pure cognitive neurology because of the exam-and-EMG core.

Best fit if: you love the localization puzzle and want a hands-on procedural skill · you want a controllable, outpatient, largely call-light neurology life · you can carry the emotional weight of terminal/progressive disease and find meaning in longitudinal care · you value fit and longevity over maximizing salary · you like being the referral endpoint for the hardest weakness and neuropathy cases.

Not for you if: you want fast cures and can't sit with terminal disease · you're choosing a subspecialty primarily to raise income · you dislike procedures/EMG or find rare-disease ambiguity draining · you want a fully call-free job from day one (general call may still be bundled) · you want maximal remote/telehealth flexibility.

The FLI angle — Neuromuscular Medicine for first-gen, low-income & immigrant students

Where neuromuscular fits FLI realities well:

  • Genuinely accessible at both stages. The parent, Neurology, takes DO and IMG graduates at close to the all-specialty rate (18.8% DO and 22.4% IMG of the PGY-1 positions that filled in 2026, against 21.5% and 25.2% across all PGY-1 positions), which is a different world from the closed surgical subspecialties, and PM&R is also comparatively DO-friendly, giving you two reachable on-ramps. The fellowship itself runs more open still, at 16.3% DO and 24.4% international medical school among its 86 fellows.18 The fellowship itself is not competitive, and spots regularly go unfilled while NM and EMG demand stays high, so a DO or IMG who completes a neurology or PM&R residency has a realistic, non-gatekept path in.7
  • Low added opportunity cost. The fellowship adds just one year (vs. the 2–3 years of the procedural subspecialties), and attending pay lands in the solid upper-middle general-neuro range (~$245k–$310k).1012
  • A procedural income lever if you need it. The honest caveat is that the fellowship year is unlikely to raise your salary much over practicing general neurology, but building EMG-lab volume can add meaningfully to income for someone who needs to accelerate loan repayment.13
  • Geographic flexibility. NM and EMG demand exists broadly rather than only in academic hubs, so you can practice near family or in a lower-cost market, though it's somewhat less remote-friendly than pure cognitive or headache neurology because the exam and in-person EMG cap full telehealth.3
  • PSLF-aligned. The interesting neuromuscular work of MDA/ALS multidisciplinary clinics, biopsy labs, and clinical trials concentrates at academic and hospital-employed jobs, which are frequently 501(c)(3) non-profit employers that qualify for Public Service Loan Forgiveness; neurology's advertised loan-forgiveness offers already run wide ($10k–$400k). For a debt-loaded FLI grad, an academic NM job can pair loved work with 10-year federal forgiveness.1 PSLF rules shift with policy, so check where they stand before you plan around them.

Risks to name honestly:

  • The emotional cost is the real price of entry. ALS decline, delivered repeatedly, is easy to underestimate from the outside, and it's the thing to test by shadowing an ALS/MDA clinic before committing.15
  • It's not an income play. If your situation demands maximizing earnings fast, procedural subspecialties (or high-volume EMG specifically) do more; NM's median won't clear general neurology by much.1012
  • EMG reimbursement has been cut and could shift again, so don't bank the fellowship on procedural billing staying rich.13
  • The prior-auth/administrative grind for expensive biologics is inherited from neurology and is real.3

Bottom line: neuromuscular medicine is an accessible (DO/IMG-open, uncompetitive fellowship), stable-demand, geographically flexible, PSLF-friendly subspecialty with one of the calmer schedules in neurology, a field chosen for craft, meaning, and career longevity rather than for a pay bump. The schedule is kind; the emotional weight is the true test. Shadow an ALS/MDA multidisciplinary clinic before you commit.

Fun facts

  • Neuromuscular medicine is one of the few ABMS subspecialties co-owned by two boards, ABPN (neurology) and ABPMR (physiatry), reflecting that neurologists and physiatrists both practice it. The joint committee dates to 2005; the first exam was in 2008.45
  • The field's signature tool, the EMG, is a procedure the neuromuscular physician both performs and reads, a rare hands-on craft in an otherwise cognitive specialty and the reason NM overlaps so heavily with Clinical Neurophysiology.12
  • Spinal muscular atrophy went from a leading genetic cause of infant death to a treatable disease in about a decade, and three transformative drugs (nusinersen, 2016; onasemnogene abeparvovec / one-time gene replacement, 2019; oral risdiplam, 2020) rewrote the prognosis.23
  • Myasthenia gravis is in the middle of its own drug wave, and new complement inhibitors and FcRn antagonists have reshaped treatment beyond the old steroids, IVIG, and plasma-exchange playbook.24
  • Watch the initials: the electrodiagnostic board neuromuscular physicians often hold is ABEM, the American Board of Electrodiagnostic Medicine, not the emergency-medicine board of the identical acronym.2
  • Neuromuscular physicians read muscle and nerve biopsies and perform skin punch biopsies for small-fiber neuropathy, a diagnostic reach into pathology that few other neurologists have.1

Sources

Footnotes

  1. Neuromuscular scope, procedures, and training overview — ABPN Neuromuscular Medicine subspecialty page (https://abpn.org/become-certified/taking-a-subspecialty-exam/neuromuscular-medicine/, 2025). Kept consistent with the neurology profile on this site, which is where the parent-field facts (hours, loan-forgiveness range, setting pay) are carried from; that is a cross-reference rather than a source, and the underlying sources are cited on that page and in the notes below. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10

  2. UNC Neuromuscular Medicine Fellowship — day-to-day structure ("4–5 half-days," clinic/EMG-lab split), advanced electrodiagnostics (single-fiber EMG, repetitive nerve stimulation), skin biopsy, dual board eligibility, and the ABEM (electrodiagnostic-medicine) / AANEM neuromuscular-ultrasound credentials. https://www.med.unc.edu/neurology/education-and-training/fellowship-opportunities/neuromuscular-1/ (2025). AANEM Neuromuscular Ultrasound CAQ: https://www.aanem.org/abem/home/physician-certification/neuromuscular-ultrasound-certificate-of-added-qualification/certification-requirements (2025). ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8

  3. Neuromuscular lifestyle, wellbeing, and culture — synthesized from paraphrased SDN / r/Neurology community sentiment (low acute call, procedure-day inbox relief, "worth it for longevity not money," EMG reimbursement cuts, referral-EMG model, NM-vs-CNP debate, general-call bundling, personality fit) and neurology-parent lifestyle facts from the neurology profile on this site. SDN threads at 202122. AMA, "What neurologists are doing to combat high burnout" (https://www.ama-assn.org/practice-management/physician-health/what-neurologists-are-doing-combat-high-burnout). Community sentiment is paraphrased, not fact — ⟳ verify. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15

  4. ABPN — Neuromuscular Medicine subspecialty certification: 1-year ACGME-accredited fellowship; joint ABPN/ABPMR Committee on Certification established Dec 2, 2005; first exam 2008; eligible primary boards (Neurology, Child Neurology, PM&R); 10-year continuing certification. https://abpn.org/become-certified/taking-a-subspecialty-exam/neuromuscular-medicine/ and https://abpn.org/accordion/neuromuscular-medicine-history-and-statement-of-principles/ (accessed 2026). ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  5. ABPMR — Neuromuscular Medicine subspecialty (PM&R pathway, shared certification with ABPN): 12-month ACGME-accredited fellowship, ≥6 months direct clinical neuromuscular care. https://www.abpmr.org/Subspecialties/Neuro (accessed 2026). ACGME Program Requirements — Neuromuscular Medicine (2025): https://www.acgme.org/globalassets/pfassets/programrequirements/2025-reformatted-requirements/183_neuromuscular-medicine_2025_reformatted.pdf ↩ ↩2 ↩3 ↩4 ↩5

  6. AANEM — Neuromuscular Ultrasound Certificate of Added Qualification requirements. https://www.aanem.org/abem/home/physician-certification/neuromuscular-ultrasound-certificate-of-added-qualification/certification-requirements (2025). ↩

  7. AANEM — Neuromuscular Medicine Fellowship Portal: ~47 programs listed for 2027–28 (~45 ACGME-accredited, ~2 non-accredited); more than half of programs with unfilled positions in a recent snapshot; rolling applications to unfilled programs through Sept 30. https://www.aanem.org/clinical-practice-resources/careers/fellowships/neuromuscular-medicine-fellowship-portal (accessed 2026-07; program/position counts ⟳ verify — portal updates by cycle). Corrected 2026-08-17: this bullet gave the portal's ~47 as the size of the field. The portal lists programs that participate in it, which is not every accredited program, and ACGME's own count for AY2024-25 is 59. Nothing here was false about the portal, but the reader was handed the smaller number as the field's size, and the larger one makes this page's own accessibility argument better rather than worse. Both counts now appear, labeled. They are also not the same year — the portal figure is for 2027–28 and the ACGME figure for AY2024-25 — which is a second reason to print them side by side rather than to replace one with the other. See 9. ↩ ↩2 ↩3 ↩4 ↩5

  8. London ZN et al., "The Neuromuscular Portal and Match: Working Toward a More Fair, Equitable, and Transparent Process," Muscle & Nerve / Neurology Education (2022) — non-binding centralized portal, not an NRMP-style binding match. https://www.neurology.org/doi/10.1212/NE9.0000000000200086 ; https://pubmed.ncbi.nlm.nih.gov/35213933/ (abstracts; full text robots-blocked this pass — applicant/position counts ⟳ verify). ↩ ↩2

  9. Burnout (parent neurology, standing in for absent NM data) — Medscape Physician Burnout & Depression Report 2024 (n=9,226, fielded July–October 2023), neurology 44% against an all-physician average of 49%. The report is paywalled and returns HTTP 402, so the specialty rows are read through three independent relays that agree on the edition, the instrument and every row: Healthgrades Pro (https://resources.healthgrades.com/pro/the-most-and-least-burned-out-physicians-by-specialty) and Advisory Board (https://www.advisory.com/daily-briefing/2024/01/31/physician-burnout). Field-synthesis reporting places neurology higher (~48–55%). No NM-specific figure exists. ⟳ verify. ↩ ↩2 ↩3 ↩4

  10. AMN Healthcare — Neurologist Salary Report 2025: general neurology average $244,000 (starting ~$200,000); neuromuscular not separately listed (used as the general-neuro floor for NM). https://www.amnhealthcare.com/blog/physician/perm/neurologist-salary-report-2025/ (2025). ⟳ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7

  11. Removed 2026-08-13. This footnote carried a ZipRecruiter average, percentile ladder and range for "Neuromuscular Neurologist," and a bullet quoting them sat in the compensation section. Job postings are title-matched and have no panel or sample size behind them. The national figure is unchanged and rests on AMN 2025 and the AAN's 2025 survey. ⟳ verify. ↩ ↩2

  12. AAN — 2025 Neurology Compensation & Productivity Report, Executive Summary: general-neurology median $309,882; by-setting medians (hospital-based group $362,500 · multispecialty $350,000 · single-specialty $315,489 · solo $300,000 · academic medical center $277,288 · government $255,000); neuromuscular not shown in the public summary. https://www.aan.com/siteassets/home-page/tools-and-resources/practicing-neurologist--administrators/benchmarking-data/neurology-compensation--productivity/25-ncp-executive-summary.pdf (2025). ⟳ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9

  13. EMG/NCS electrodiagnostic billing as the neuromuscular revenue lever (~$100k–$150k over clinic-only, community estimate), and recent CMS reimbursement cuts to electrodiagnostic codes; in-office IVIG/biologic infusion revenue (CIDP, myasthenia). AANEM coding resources (https://www.aanem.org/clinical-practice-resources/billing-coding/member-only-coding-resources); Bonfire Revenue Neurology EMG Billing Guide (https://www.bonfirerevenue.com/neurology-emg-billing-and-coding-guide/); FastRVU Neurology (https://fastrvu.com/specialties/neurology); CMS Nerve Conduction/EMG LCD (https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=54992). ⟳ verify. Corrected 2026-08-17: the body called the ~$100k–$150k figure "the community estimate" and said in the same sentence that "no source cleanly quantifies the per-physician premium." Both were wrong in the same direction. FastRVU, cited in this footnote, states it outright — "Neurologists with EMG labs earn $100K-$150K more than clinic-only practices" — and calls electrodiagnostics the differentiator in neurology income. Describing a published figure as unattributed folklore is the defect; the caution itself is defensible, because an aggregator is not a survey. The sentence now says where the figure sits on that scale. Blocked pending a licensed survey: fastrvu.com is a host this site's compensation standard excludes, and that standard's remedy is removal and re-research rather than more accurate re-quotation. That re-research is still open, and the figure is left in place with its provenance stated rather than deleted, since it is the only quantification of this field's central earning lever. Corrected 2026-08-17: a figure of this kind stays with the host named rather than being removed. FastRVU is now named in the visible sentence that carries the ~$100k–$150k premium, so the reader learns whose figure it is at the point they read it rather than only here. ↩ ↩2 ↩3 ↩4 ↩5

  14. Neurology "infusion boom" revenue context (in-office biologic/infusion administration for MS, myasthenia, CIDP, migraine, Alzheimer's) — carried from the neurology profile on this site; ADSC, "What Neurology Practices Must Know About 2026 Billing Changes." https://www.adsc.com/blog/what-neurology-practices-must-know-about-2026-billing-changes (no clean per-physician $ effect — verify). ↩

  15. ALS emotional load and the multidisciplinary-clinic relationship — AMA Journal of Ethics, "How Should Physicians Care for Dying Patients with Amyotrophic Lateral Sclerosis?" (2018). https://journalofethics.ama-assn.org/article/how-should-physicians-care-dying-patients-amyotrophic-lateral-sclerosis/2018-08 ; Dove Press, ALS multidisciplinary care (https://www.dovepress.com/amyotrophic-lateral-sclerosis-improving-care-with-a-multidisciplinary--peer-reviewed-fulltext-article-JMDH). ↩ ↩2 ↩3

  16. Would-choose-again — no publisher. Medscape stopped reporting a would-choose-again figure by specialty around 2019, and the paired burnout / would-choose-again tables circulating on salary and career aggregator sites are unsourced revivals of that retired table. There is no current overall anchor for physicians as a whole either; the most recent traceable Medscape datapoint of any kind is 68% among physicians under 40, from the 2022 Young Physician Compensation Report, with no specialty breakdown. An earlier version of this profile carried a "~78% would choose medicine again" figure, which was removed on 2026-08-13 because no source publishes it. A different Medscape 2025 question asks whether doctors in a specialty can be happy and well balanced, and it is a different claim. ↩

  17. Women (parent neurology, standing in for absent NM data) — practicing figure from AAMC, "Women are changing the face of medicine in America" (2022 data), https://www.aamc.org/news/women-are-changing-face-medicine-america, which puts neurology at 33%. The all-physician share is 38.7% on 2024 data: AAMC, 2025 Key Findings, https://www.aamc.org/data-reports/data/2025-key-findings. The resident figure is 50.2% women for academic year 2024-25: ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21, https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf. Correction 2026-08-13: this page previously carried ~40% of neurology residents, in the Quick dashboard and in Who's in the field. Neuromuscular fellows are counted in the same table: 59 programs, 86 active fellows, 46 of them women (53.5%). AAMC has no neuromuscular practicing figure, because it excludes any specialty under 2,500 active physicians. Corrected 2026-08-17: this page said the neuromuscular share was "not separately reported" and stood the parent field in for it. Table C.21 reports it, twelve rows from the neurology row this footnote was already citing, and it comes out above the parent rather than below. ⟳ verify. ↩

  18. DO and IMG accessibility. Neuromuscular fellows: ACGME, Data Resource Book, Academic Year 2024-2025, Table C.15, https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf — 86 fellows, 46 U.S. LCME graduates (53.5%), 21 international medical school (24.4%), 14 osteopathic (16.3%), 5 Canadian (5.8%). Parent neurology: NRMP, Results and Data: 2026 Main Residency Match, May 2026, Table 2, https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf — neurology PGY-1 offered 1,003 and filled 999, of which 188 went to DO seniors and graduates (18.8%) and 224 to U.S. and non-U.S. IMGs (22.4%), against 583 U.S. MD seniors (58.4%). The same table's all-PGY-1 totals row gives 21.5% DO and 25.2% IMG of 38,354 filled positions, which is the comparison the FLI section uses. All of these are shares of filled positions, which is who got in rather than a DO or IMG applicant's chance of matching. Corrected 2026-08-17: the dashboard, the demographics section and the FLI section all carried ~16.5% DO and ~29% IMG from the 2025 cycle, and said the fellowship's own shares were unpublished. Both statements were wrong: this footnote already held the current parent figures, and Table C.15 publishes the fellowship's own. The FLI section's "one of the most DO- and IMG-open base residencies" was rewritten with them, because neurology sits slightly below the all-PGY-1 rate on both axes rather than at the top of the field. Swept 2026-08-17: verified against Table 2 and unchanged. All eleven profiles in the neurology family now state 18.8% DO and 22.4% IMG on the positions-filled denominator, from this source. ⟳ verify. ↩ ↩2 ↩3

  19. URiM — there is no current race-by-specialty table for physicians anywhere, so the below-average characterization of neurology rests on AAMC's Diversity in Medicine 2019 and on AAN's own diversity reporting, both dated. What is current is the aggregate across all active physicians in 2024: White 56.1%, Asian 19.8%, Hispanic or Latino 6.7%, Black or African American 5.3%, American Indian or Alaska Native 0.3%. AAMC, 2025 Key Findings, https://www.aamc.org/data-reports/data/2025-key-findings. No neuromuscular-specific figure exists. ⟳ verify. ↩

  20. SDN — "Is a neuromuscular fellowship worth it financially (and how competitive is U of M neuromuscular)" — paraphrased community argument that NM is a fit/longevity choice, not a salary play. https://forums.studentdoctor.net/threads/is-a-neuromuscular-fellowship-worth-it-financially-and-how-competitive-is-u-of-m-neuromuscular.1477518/ ↩ ↩2

  21. SDN — "Pros and cons of neuromuscular fellowship" — paraphrased: good-lifestyle field with minimal emergency responsibility; training adds real depth (biopsy interpretation, immunotherapy) beyond electrodiagnostics. https://forums.studentdoctor.net/threads/pros-and-cons-of-neuromuscular-fellowship.1451547/ ↩ ↩2

  22. SDN — "Movement vs neuromuscular" — paraphrased: NM appeals to those who value longitudinal relationships and procedural ownership and can shoulder progressive-disease investment. https://forums.studentdoctor.net/threads/movement-vs-neuromuscular.1487597/ ↩ ↩2

  23. SMA therapeutics (nusinersen 2016; onasemnogene abeparvovec/Zolgensma 2019, label broadened 2025; risdiplam 2020) — AJMC, FDA broadens onasemnogene abeparvovec SMA approval (2025), https://www.ajmc.com/view/fda-approves-gene-therapy-onasemnogene-abeparvovec-for-broader-sma-population ; Nature Gene Therapy, gene-based SMA therapy review (2024), https://www.nature.com/articles/s41434-024-00503-8?error=cookies_not_supported&code=4b1821c7-ca8c-4da6-a986-06d803ebc1f5. ↩

  24. Myasthenia gravis next-generation biologics (complement inhibitors, FcRn antagonists) — J Neurol (Springer), MG "five new things" (2025), https://link.springer.com/article/10.1007/s00415-025-12922-7 ; Practical Neurology, next-generation MG treatments, https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-notes-next-generation-treatments-for-myasthenia-gravis/31666/. ↩

Researched with AI assistance and reviewed by hand. How this site is made